Home

Research

Alzheimer's Disease

Read time: 3 min

Congress highlights

Who might benefit most from a personalized treatment plan to support brain health?

"Individuals vary in their resilience or vulnerability to Alzheimer’s disease", said Professor...

Read time: 2 min

Congress highlights

Raising the healthcare prioritization of headache: Why and how?

Headache is the most common neurologic disorder but the least acknowledged, said Professor Rigmor...

Alzheimer's Disease

Read time: 2 min

Satellite symposium

Interactions between the brain and the immune system

At the 35th ECNP Congress in Vienna, Austria (15th−18th Oct), Professor Jonathan Kipnis (...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Preventive and new therapeutic strategies

Current progress in preventive and new therapeutic strategies for Alzheimer’s disease were...

Read time: 3 min

Congress highlights

New insights into the pathophysiology and clinical manifestations of schizophrenia

New insights into the genetic risk for schizophrenia, the role of inflammation in schizophrenia...

Read time: 3 min

Congress highlights

Real world evidence or clinical trials – what informs clinical practice the most?

In a scientific session at the 16th European Headache Congress, Vienna, Austria, the expert faculty...

Read time: 3 min

Congress highlights

Lancet–World Psychiatric Association Commission on depression

A joint Lancet and World Psychiatric Association Commission on depression calls for a united action...

Neurotoriun

Neurotorium is your new point of reference for educational content on psychiatry, neurology, and neuroscience.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Belux

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country